Catalyst Event
GeneDx Holdings Corp (WGS) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/4/2026, 12:00:00 AM
GeneDx Holdings Corp. is scheduled to release its financial results for the first quarter of 2026 after the market closes on May 4, 2026. Analysts forecast earnings of ($0.06) per share and revenue of $112.45 million. This event is expected to cause a price impact of at least 5% based on historical volatility, scheduled.
Korean Translation
GeneDx Holdings Corp.는 2026년 5월 4일 장 마감 후 2026년 1분기 재무 결과를 발표할 예정임. 분석가들은 주당 순이익 (0.06달러), 매출 1억 1,245만 달러를 전망함. 과거 변동성을 고려할 때 5% 이상의 주가 영향이 예상되며, 2026년 5월 4일 실적 발표 예정됨.
Related Recent Events
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date for the final dividend of RMB 1.43 per share for the fiscal year 2025 on 2026-06-16, scheduled.
6/16/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
Annual General Meeting to be held on 2026-05-21 to review reports and approve plans; routine meetings typically have a 1-5% price impact, scheduled
5/21/2026, 12:00:00 AM
Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Other
An earnings briefing for the 2025 fiscal year and Q1 2026 results is scheduled for May 14, 2026. This routine communication event is estimated to have a price impact of at least 1% scheduled.
5/14/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
Caris Life Sciences to report first quarter 2026 financial results on May 7, 2026, scheduled.
5/7/2026, 12:00:00 AM
Guardant Health Inc (GH) · Earnings Release
Guardant Health is scheduled to release its Q1 2026 financial results after market close on May 7, 2026. Analysts forecast EPS of ($0.47) and revenue of $279.17 million. High importance estimated due to potential for significant volatility following earnings results, scheduled.
5/7/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is scheduled to release its first quarter 2026 financial results after the market closes on May 7, 2026, with analysts forecasting revenue of approximately $617.5 million and an EPS of -$0.55; high importance is expected due to typical earnings volatility, scheduled.
5/7/2026, 12:00:00 AM